OTC · DTRK
Healthcare · Medical - Healthcare Information Services
$0.31
Up+$0.02 (+6.90%)
Updated Aug 23, 2026, 1:09 PM
SID Score
2.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 7 trading sessions · Daily adjusted prices
DTRK closed at $0.31 after 7 trading sessions, up 25.68% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $0.33 | $0.394 | $0.3142 | $0.3142 | 11.7K |
| Aug 14, 2026 | $0.29 | $0.29 | $0.29 | $0.29 | 2.5K |
| Aug 13, 2026 | $0.35 | $0.35 | $0.30 | $0.30 | 5.1K |
| Aug 12, 2026 | $0.30 | $0.35 | $0.30 | $0.35 | 7.72K |
| Aug 10, 2026 | $0.30 | $0.398 | $0.278 | $0.398 | 4.5K |
| Aug 3, 2026 | $0.25 | $0.25 | $0.25 | $0.25 | 2K |
| Jul 29, 2026 | $0.226 | $0.25 | $0.226 | $0.25 | 5K |
The latest Smart Investors Daily articles mentioning DTRK.
DTRK research
Company profile and research snapshot.
DATATRAK INTL INC
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Feb 26, 2026
eConsent solution deploys in under four weeks, integrates with any EDC, and delivers affordable, patient‑centric digital consent AUSTIN, TX / ACCESS Newswire / February 26, 2026 / DATATRAK International, Inc.'s (OTC:DTRK) DATATRAK Powered by Fountayn ...
Yahoo · Nov 11, 2025
Datatrak eSource was selected after a rigorous evaluation process of various clinical trial software systems. A key factor in the selection was Datatrak's customizable and reliably proven EDC that seamlessly integrates with all other eClinical functions ...
accessnewswire.com · Nov 11, 2025
Datatrak eSource was selected after a rigorous evaluation process of various clinical trial software systems. A key factor in the selection was Datatrak's customizable and reliably proven EDC that seamlessly integrates with all other eClinical functions to be a true eSource solution for healthcare and life sciences.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning DTRK.
No results
No recent SID articles mention DTRK.
